$1.46
-0.05 (-3.31%)
USD · as of 2026-08-18 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where GAIA is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
19 interventional · 1 observational · 1 with posted results
Held by 8 tracked-famous managers (MILLENNIUM MANAGEMENT LLC, JANE STREET GROUP, LLC, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Squarepoint Ops LLC, +3 more) · FINRA short interest 1.0 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Readout in | Updated |
|---|---|---|---|---|---|---|---|---|
| Investigating Autimia, a Digital Intervention for Patients With Autism Spectrum DisorderNCT0763865721-item Depression, Anxiety, and Stress Scales (DASS-21) total scoreRandomized · Open-label · Treatment | Not applicable | Recruiting | Behavioral: autimia | Autism Spectrum Disorder | 236 | Mar 2027 | ≤ 224 d | 2026-06-16 |
| Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DMNCT06529965Diabetes-specific emotional distressRandomized · Open-label · Treatment | Not applicable | Active, not recruiting | Behavioral: covivio | Glucose Metabolism Disorders (Including Diabetes Mellitus), Metabolic Disease, Endocrine System Diseases, Diabetes Mellitus, Type 2 | 250 | Dec 2026 | ≤ 134 d | 2026-06-15 |
| Effectiveness of a Digital Health Application for Primary Hypertension (Liebria)NCT06243978SBP (in mmHg)Randomized · Open-label · Treatment | Not applicable | Active, not recruiting | Behavioral: liebria · Other: information brochure on hypertension | Hypertension | 328 | Jun 2026 | — | 2026-06-16 |
| Investigating the Effectiveness of VimidaNCT06251518Fatigue symptom severityRandomized · Open-label · Treatment | Not applicable | Active, not recruiting | Behavioral: vimida | Long COVID, Post COVID-19 Condition | 160 | Sep 2025 | — | 2025-06-18 |
| Effects of a Digital Health Application (Lipodia) on LDL-cholesterol LevelsNCT05988866Fasting LDL-C levelsRandomized · Double-masked · Treatment | Not applicable | Completed | Behavioral: lipodia | Hypercholesterolemia, Dyslipidemias | 278 | 2026-05-22actual | — | 2026-07-07 |
| Researching the Effectiveness of a Alivis, a Digital Health Application for Borderline Personality DisorderNCT06601907results2026-03-16Borderline Symptoms List 23 (BSL-23)Randomized · Open-label · TreatmentStudy Protocol and Statistical Analysis Plan ↗ | Not applicable | Terminatedsponsor's stated reason: An unplanned interim futility analysis was initiated due to differential dropout and participant feedback. The probability of achieving the pre-specified effect size was very low, and following DSMB review, the trial was terminated early. | Behavioral: alivis | Borderline Personality Disorder (BPD) | 286 | 2025-07-23actual | — | 2026-03-16 |
| Evaluation of an Online Intervention for Female Sexual DysfunctionNCT06237166sexual functioningRandomized · Open-label · Treatment | Not applicable | Completed | Behavioral: mylovia | Female Sexual Dysfunction | 252 | 2025-02-10actual | — | 2025-08-22 |
| Effectiveness of a Digital Health Application for Subacute and Chronic Back Pain (Relevis)NCT06221956Functional ImpairmentRandomized · Open-label · Treatment | Not applicable | Unknown status | Behavioral: relevis | Back Pain | 276 | 2025-01-23 | — | 2024-02-09 |
| Effectiveness of a Digital Health Application for PsoriasisNCT06027034Health-Related Quality of LifeRandomized · Single-masked · Treatment | Not applicable | Completed | Behavioral: Online program for psoriasis (GAIA-PSO-01) | Psoriasis | 348 | 2024-12-31actual | — | 2026-06-16 |
| Effectiveness of a Digital Health Application for Multiple Sclerosis (Levidex)NCT06090305Hamburg Quality of Life Questionnaire for Multiple Sclerosis (HALEMS)Randomized · Single-masked · Treatment | Not applicable | Completed | Behavioral: levidex, Control · Other: treatment as usual (TAU) | Multiple Sclerosis | 470 | 2024-12-06actual | — | 2025-01-30 |
| Researching the Effectiveness of Attexis, a Digital Health Application for Adults With Attention Deficit Hyperactivity DisorderNCT06221930ADHD Symptom SeverityRandomized · Open-label · Treatment | Not applicable | Completed | Behavioral: attexis | Adult Attention Deficit Hyperactivity Disorder | 337 | 2024-09-25actual | — | 2025-01-27 |
| Effectiveness of a Dialogue-based Online Intervention Against MigraineNCT04276142Number of days with migraine headacheRandomized · Double-masked · Treatment | Not applicable | Completed | Behavioral: ceprica (additional to treatment as usual), active control intervention (additional to treatment as usual) | Migraine | 321 | 2024-08-20actual | — | 2024-09-05 |
| Effectiveness of an Online Self-management Intervention for Type 2 Diabetes MellitusNCT05525117HbA1cRandomized · Single-masked · Treatment | Not applicable | Withdrawnsponsor's stated reason: No participants could be recruited. | Behavioral: covivio (additional to treatment as usual) · Other: treatment as usual | Type 2 Diabetes | 0 | 2024-07-15 | — | 2024-05-28 |
| Evaluating the Effectiveness of a Digital Therapeutic (Reviga) for People With Stress or BurnoutNCT05998161Stress symptomsRandomized · Open-label · Treatment | Not applicable | Completed | Behavioral: reviga | Stress, Burnout | 290 | 2024-06-22actual | — | 2025-04-04 |
| Formative Validation of the MoveChecker SystemNCT05824611observationalmotion sequences of at least 60 epileptic seizures | — | Completed | Other: collect movement data from epileptic seizures | Epilepsy | 53 | 2023-12-31actual | — | 2024-02-09 |
| Effect of a Single Virtual Reality Exposure on Depressive Symptoms (Veovita-VR)NCT05529797Patient Health Questionnaire (PHQ-9)Randomized · Open-label · Treatment | Not applicable | Completed | Other: Veovita-VR | Depression | 128 | 2023-05-25actual | — | 2023-06-15 |
| Effectiveness of a Digital Health Application for People With Insomnia Disorder (Somnovia)NCT05558865Insomnia Severity Index (ISI)Randomized · Single-masked · Treatment | Not applicable | Completed | Behavioral: somnovia | Insomnia Disorder | 290 | 2023-05-22actual | — | 2023-09-25 |
| Evaluating an Internet-Based Self-Management Intervention for BorderlineNCT03418142Score of the Borderline Personality Disorder Severity Index (BPDSI) - The BPDSI is a semi-structured interview assessing the frequency and severity of manifestations of borderline personality disorder (BPD) during the last three months.Randomized · Single-masked · Treatment | Not applicable | Completed | Behavioral: Priovi · Other: CAU | Borderline Personality Disorder | 206 | 2020-01-29actual | — | 2020-02-24 |
| Evaluating a Novel Internet Intervention for Persons With Epilepsy and DepressionNCT02791724Severity of depressive symptoms, measured by Patient Health Questionnaire - 9 items (PHQ-9)Randomized · Open-label · Treatment | Not applicable | Completed | Behavioral: Desiconnect · Other: CAU | Depression, Epilepsy | 200 | Feb 2018actual | — | 2019-08-02 |
| Internet-Based Treatment of Depression: Comparing Guided With Unguided Self-HelpNCT04428450Beck Depression Inventory - II (BDI-II)Randomized · Open-label · Treatment | Not applicable | Completed | Device: Deprexis | Depression | 76 | 2010-12-31actual | — | 2024-02-23 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19